ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 691,98
0,39%
Dow Jones
39 112,16
-0,76%
DAX
18 274,95
0,62%
Brent Oil
84,635
0,53%
Bitcoin
61 697,29
-0,18%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Therapeutics Acquisition Corp (TXAC)

  7. Therapeutics Acquisition Corp (TXAC) Actualités

TXAC

Therapeutics Acquisition (TXAC)

Therapeutics Acquisition Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TXAC
DateHeureSourceTitreSymboleSociété
15/06/202300h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXACTherapeutics Acquisition Corp
15/06/202300h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TXACTherapeutics Acquisition Corp
05/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXACTherapeutics Acquisition Corp
01/05/202319h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TXACTherapeutics Acquisition Corp
27/04/202314h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXACTherapeutics Acquisition Corp
27/03/202313h55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXACTherapeutics Acquisition Corp
14/02/202318h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TXACTherapeutics Acquisition Corp
03/02/202318h12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TXACTherapeutics Acquisition Corp
22/11/202222h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TXACTherapeutics Acquisition Corp
14/11/202213h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXACTherapeutics Acquisition Corp
14/09/202222h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TXACTherapeutics Acquisition Corp
12/08/202214h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TXACTherapeutics Acquisition Corp
12/07/202212h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TXACTherapeutics Acquisition Corp
01/07/202222h14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TXACTherapeutics Acquisition Corp
16/05/202214h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TXACTherapeutics Acquisition Corp
18/03/202200h20Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:TXACTherapeutics Acquisition Corp
15/02/202200h53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:TXACTherapeutics Acquisition Corp
08/02/202220h25Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXACTherapeutics Acquisition Corp
30/07/202122h52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TXACTherapeutics Acquisition Corp
12/07/202122h38Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TXACTherapeutics Acquisition Corp
08/07/202117h39Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:TXACTherapeutics Acquisition Corp
21/06/202122h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TXACTherapeutics Acquisition Corp
07/06/202112h01Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:TXACTherapeutics Acquisition Corp
23/03/202111h07Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:TXACTherapeutics Acquisition Corp
18/03/202114h09Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TXACTherapeutics Acquisition Corp
06/10/202019h29InvestorsHub NewsWire(GNBT,PAOG) SPAC Trend Comes To Biotech MarketNASDAQ:TXACTherapeutics Acquisition Corp
10/07/202022h15Business WireTherapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Closing of $135.7 Million Initial Public ...NASDAQ:TXACTherapeutics Acquisition Corp
08/07/202018h25Business WireTherapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial P...NASDAQ:TXACTherapeutics Acquisition Corp
 Showing the most relevant articles for your search:NASDAQ:TXAC

Dernières Valeurs Consultées

USOTC
NAJSF
North Atlantic Smaller C... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés